Johnson & Johnson (JNJ) stock news · P/E 17, rev $49.37B
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
This JNJ news page leads with what Johnson & Johnson filed — not a scraped headline mill.
No cached 8-K sentence for JNJ yet. We will not pad this page with generic market recap.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the JNJ stock page; for the tape open the quote page.
Not investment advice.